TACMIS

2011 ◽  
pp. 1770-1781
Author(s):  
M. Cassim

TACMIS is an inclusive solution to the management of health care and medical information and its design is based on a detailed process analysis of patient journeys and the pathways of clinical care of stroke patients as they progress from acute care, through rehabilitation to discharge and independent living, often with a residual disability. The findings are the work of a team based in the Discovery Research Laboratory at Ritsumeikan University in Japan. The clinical analysis was conducted at King’s College Hospital in London and in several care institutions for the disabled and the aged in Japan.

Author(s):  
M. Cassim

TACMIS is an inclusive solution to the management of health care and medical information and its design is based on a detailed process analysis of patient journeys and the pathways of clinical care of stroke patients as they progress from acute care, through rehabilitation to discharge and independent living, often with a residual disability. The findings are the work of a team based in the Discovery Research Laboratory at Ritsumeikan University in Japan. The clinical analysis was conducted at King’s College Hospital in London and in several care institutions for the disabled and the aged in Japan.


2020 ◽  
Author(s):  
Katie White ◽  
Alina Ivan ◽  
Ruth Williams ◽  
James B Galloway ◽  
Sam Norton ◽  
...  

BACKGROUND Rheumatoid arthritis (RA) is characterised by recurrent fluctuations in symptoms such as joint pain, swelling and stiffness. Remote Measurement Technologies (RMTs) offer the opportunity to track symptoms continuously and in real-time, and therefore may provide a more accurate picture of RA disease activity as a complement to pre-scheduled GP appointments. Previous research has shown patient interest in symptom-tracking apps for RA, as well as provided evidence for its clinical validity. However, it remains unclear which features of RMTs best promote optimal engagement. OBJECTIVE The objective of this study was to determine the important outcomes for disease-management for patients with RA, and how these can be best captured via a remote measurement app. METHODS Nine patients with RA were recruited from King’s College Hospital to participate in two semi-structured focus groups. Ages ranged from 23 to 77 years (M = 55.78, SD = 17.54) Both discussions were conducted by a facilitator and a lived-experience researcher. Sessions were recorded, transcribed, independently coded and analysed for themes. RESULTS Thematic analysis identified a total of four overarching themes: (1) important symptoms and outcomes in RA, (2) management of RA symptoms, (3) views on the current healthcare system, and (4) views on the use of RMT in RA. Key health, work and social factors were highlighted as important outcomes in RA disease management. There was general consensus that the ability to track symptoms (pain, mobility) and transmit such data to clinicians would aid towards individual symptom management and effectiveness of clinical care. Suggestions for capturing symptom fluctuations visually in an app were put forward. CONCLUSIONS Findings support previous work on the acceptability of RMT with RA disease management, and address key outcomes for integration into an app for RA symptom tracking.


BMJ ◽  
1857 ◽  
Vol s4-1 (35) ◽  
pp. 728-729

BMJ ◽  
1859 ◽  
Vol s4-1 (138) ◽  
pp. 666-667

The Lancet ◽  
1864 ◽  
Vol 83 (2112) ◽  
pp. 210-211
Author(s):  
Watson

1986 ◽  
Vol 5 (3) ◽  
pp. 201-206 ◽  
Author(s):  
R. B. Read ◽  
J. M. Tredger ◽  
R. Williams

1 To determine reasons for the continuing mortality in patients taking a paracetamol overdose, the presentation, drug ingestion history, patient background, use of antidote ( N-acetylcysteine and methionine), clinical course and outcome were determined in 247 patients treated at King's College Hospital in 1982 and 1983. Patients (147) were referred from other centres because of severe liver damage and 100 were local patients seen in the accident and emergency department. 2 Survival in the local patients was 100% and, for those with severe liver damage, 49 and 63% (1982 and 1983 values). Delay in initial presentation to hospital was a major factor in determination of an adverse outcome, with a median delay of 30 h in the referred patients and 8 h in the local cases. Such a delay precluded administration of antidote to the majority of patients in the referred group, but in 11 cases where antidote could have been given a full course was not provided and all 11 patients died. Included among these were four patients in whom the serum paracetamol concentration was in the ‘non-toxic’ range. 3 One patient with a chronic alcohol-drinking history (> 200 g/day) received N-acetylcysteine at 12 h but died from liver failure. However, in the complete series prior alcohol consumption was not associated with a significantly worse prognosis and simultaneous ingestion of alcohol with paracetamol had no effect on outcome. 4 The concomitant ingestion of dextropropoxyphene caused an early and marked impairment of consciousness unrelated to any hepatotoxicity but, in three cases where dextropropoxyphene combinations were used, death occurred subsequently from liver failure.


The Lancet ◽  
1857 ◽  
Vol 70 (1774) ◽  
pp. 221
Author(s):  
Henry Lee

The Lancet ◽  
1858 ◽  
Vol 71 (1816) ◽  
pp. 604
Author(s):  
Fergusson

Sign in / Sign up

Export Citation Format

Share Document